Because purinergic receptors share common agonists and form heteromeric receptors with distinct pharmacologic profiles, unraveling the contribution of intracellular P2 receptor cross-talk to salivary gland dysfunction in animal models and humans will further define their therapeutic value in the treatment of salivary gland disorders. The gene discussed is P2RY1; the disease is salivary gland disorder.